The most important numbers to know about Esperion Therapeutics Inc. (NASDAQ:ESPR)

Esperion Therapeutics Inc. (NASDAQ:ESPR) shares traded 4.72% higher at $1.33 on Wall Street last session. In accordance with the data, 9 analysts cover Esperion Therapeutics Inc. (NASDAQ:ESPR). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a low of $2.00, […]

How Do Esperion Therapeutics Inc. (NASDAQ:ESPR)’s Fundamentals Affect Performance

The price of Esperion Therapeutics Inc. (NASDAQ:ESPR) shares last traded on Wall Street fell -6.26% to $0.91. Based on available information, 8 analysts follow Esperion Therapeutics Inc. (NASDAQ:ESPR). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and a low of […]

Is Esperion Therapeutics Inc. (NASDAQ:ESPR) being unfairly punished by investors?

The price of Esperion Therapeutics Inc. (NASDAQ:ESPR) shares last traded on Wall Street fell -6.10% to $0.99. ESPR stock price is now -32.43% away from the 50-day moving average and -66.56% away from the 200-day moving average. The market capitalization of the company currently stands at $105.48M. In other news, Warren Eric, Chief Commercial Officer […]

A breakdown of the latest mutual funds holding Esperion Therapeutics Inc. (ESPR)

Stocks of Esperion Therapeutics Inc. (NASDAQ:ESPR) traded higher last session on Wall Street, down -5.22% to $1.09. According to the data, Esperion Therapeutics Inc. (NASDAQ:ESPR) has 8 analysts covering its stock. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $22.00 and […]